217 related articles for article (PubMed ID: 18332850)
1. K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries.
Ploug KB; Boni LJ; Baun M; Hay-Schmidt A; Olesen J; Jansen-Olesen I
Br J Pharmacol; 2008 May; 154(1):72-81. PubMed ID: 18332850
[TBL] [Abstract][Full Text] [Related]
2. K ATP channels in pig and human intracranial arteries.
Ploug KB; Sørensen MA; Strøbech L; Klaerke DA; Hay-Schmidt A; Sheykhzade M; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2008 Dec; 601(1-3):43-9. PubMed ID: 18996111
[TBL] [Abstract][Full Text] [Related]
3. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
[TBL] [Abstract][Full Text] [Related]
4. Different molecular sites of action for the KATP channel inhibitors, PNU-99963 and PNU-37883A.
Cui Y; Tinker A; Clapp LH
Br J Pharmacol; 2003 May; 139(1):122-8. PubMed ID: 12746230
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.
Wellman GC; Barrett-Jolley R; Köppel H; Everitt D; Quayle JM
Br J Pharmacol; 1999 Oct; 128(4):909-16. PubMed ID: 10556925
[TBL] [Abstract][Full Text] [Related]
6. Presence and vascular pharmacology of KATP channel subtypes in rat central and peripheral tissues.
Ploug KB; Baun M; Hay-Schmidt A; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2010 Jul; 637(1-3):109-17. PubMed ID: 20361954
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
Teramoto N
Cardiovasc Drug Rev; 2006; 24(1):25-32. PubMed ID: 16939631
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of KATP channels in the rat tail artery by neurally released noradrenaline acting on postjunctional alpha2-adrenoceptors.
Tan JH; Al Abed A; Brock JA
J Physiol; 2007 Jun; 581(Pt 2):757-65. PubMed ID: 17379634
[TBL] [Abstract][Full Text] [Related]
9. Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
Tomoda T; Yunoki T; Naito S; Ito Y; Teramoto N
Eur J Pharmacol; 2005 Nov; 524(1-3):1-10. PubMed ID: 16242124
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of aortic KIR6.1 and SUR2B in hypertension does not correlate with changes in the functional role of K(ATP) channels.
Blanco-Rivero J; Gamallo C; Aras-López R; Cobeño L; Cogolludo A; Pérez-Vizcaino F; Ferrer M; Balfagon G
Eur J Pharmacol; 2008 Jun; 587(1-3):204-8. PubMed ID: 18471810
[TBL] [Abstract][Full Text] [Related]
11. K(ATP) channel openers in the trigeminovascular system.
Ploug KB; Amrutkar DV; Baun M; Ramachandran R; Iversen A; Lund TM; Gupta S; Hay-Schmidt A; Olesen J; Jansen-Olesen I
Cephalalgia; 2012 Jan; 32(1):55-65. PubMed ID: 22144717
[TBL] [Abstract][Full Text] [Related]
12. A soluble epoxide hydrolase inhibitor--8-HUDE increases pulmonary vasoconstriction through inhibition of K(ATP) channels.
Liu Y; Zhang J; Yu L; Cao F; Rao J; Li J; Jiang C; Falck JR; Jacobs ER; Zhu D
Pulm Pharmacol Ther; 2012 Feb; 25(1):69-76. PubMed ID: 22155000
[TBL] [Abstract][Full Text] [Related]
13. [Ontogeny of sulphonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium].
Lovász N; Ducza E; Gáspár R; Falkay G
Acta Pharm Hung; 2011; 81(3):101-7. PubMed ID: 22165413
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the subtype-selective inhibition of cloned KATP channels by PNU-37883A.
Kovalev H; Quayle JM; Kamishima T; Lodwick D
Br J Pharmacol; 2004 Mar; 141(5):867-73. PubMed ID: 14757705
[TBL] [Abstract][Full Text] [Related]
15. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
Meisheri KD; Humphrey SJ; Khan SA; Cipkus-Dubray LA; Smith MP; Jones AW
J Pharmacol Exp Ther; 1993 Aug; 266(2):655-65. PubMed ID: 8355199
[TBL] [Abstract][Full Text] [Related]
16. Ontogeny of sulfonylurea-binding regulatory subunits of K(ATP) channels in the pregnant rat myometrium.
Lovasz N; Ducza E; Gaspar R; Falkay G
Reproduction; 2011 Jul; 142(1):175-81. PubMed ID: 21527399
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
Löffler-Walz C; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):230-7. PubMed ID: 9750009
[TBL] [Abstract][Full Text] [Related]
18. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
[TBL] [Abstract][Full Text] [Related]
19. Renal and vascular effects of chemically distinct ATP-sensitive K+ channel blockers in rats.
Ludens JH; Clark MA; Smith MP; Humphrey SJ
J Cardiovasc Pharmacol; 1995 Mar; 25(3):404-9. PubMed ID: 7769805
[TBL] [Abstract][Full Text] [Related]
20. The molecular site of action of K(ATP) channel inhibitors determines their ability to inhibit iNOS-mediated relaxation in rat aorta.
Wilson AJ; Clapp LH
Cardiovasc Res; 2002 Oct; 56(1):154-63. PubMed ID: 12237176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
